Literature DB >> 9571473

The natural history of post-traumatic reflex sympathetic dystrophy.

A Zyluk1.   

Abstract

The paper presents the results of a prospective trial to examine the natural history of early reflex sympathetic dystrophy (RSD). Thirty patients with post-traumatic RSD of the hand were observed without treatment. They were reassessed 1, 2 and 6 months after diagnosis with a final assessment at 10 to 18 months (average 13 months). Twenty-seven patients completed the study. Three were withdrawn during the study because of persistence of signs and symptoms of RSD and were given further treatment. Of the 27 patients who completed the study, only one showed sufficient features of the condition to warrant the diagnosis of mild RSD. In the remaining 26, most features of RSD had resolved spontaneously. Pain and swelling disappeared more quickly than other features of RSD. Although the signs and symptoms of RSD had largely gone at 13 months, the hands were still functionally impaired because of weaker grip strength.

Entities:  

Mesh:

Year:  1998        PMID: 9571473     DOI: 10.1016/s0266-7681(98)80211-8

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  16 in total

1.  Reflex sympathetic dystrophy: a retrospective epidemiological study of 168 patients.

Authors:  Iltekin Duman; Umit Dincer; Mehmet Ali Taskaynatan; Engin Cakar; Ilknur Tugcu; Kemal Dincer
Journal:  Clin Rheumatol       Date:  2007-01-13       Impact factor: 2.980

Review 2.  Clinical presentation and surgical anatomy of sympathetic nerve injury during lumbar spine surgery: a narrative review.

Authors:  Bradley Brickman; Mina Tanios; Devon Patel; Hossein Elgafy
Journal:  J Spine Surg       Date:  2022-06

3.  Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 5th Edition.

Authors:  R Norman Harden; Candida S McCabe; Andreas Goebel; Michael Massey; Tolga Suvar; Sharon Grieve; Stephen Bruehl
Journal:  Pain Med       Date:  2022-06-10       Impact factor: 3.637

Review 4.  Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II.

Authors:  Keith M Smart; Michael C Ferraro; Benedict M Wand; Neil E O'Connell
Journal:  Cochrane Database Syst Rev       Date:  2022-05-17

5.  The effect of sequel symptoms and signs of Complex Regional Pain Syndrome type 1 on upper extremity disability and quality of life.

Authors:  Serpil Savaş; Hale Hekim Baloğlu; Gökçen Ay; Sevim Süreyya Cerçi
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

6.  Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms.

Authors:  Zsuzsanna Helyes; Valéria Tékus; Nikolett Szentes; Krisztina Pohóczky; Bálint Botz; Tamás Kiss; Ágnes Kemény; Zsuzsanna Környei; Krisztina Tóth; Nikolett Lénárt; Hajnalka Ábrahám; Emmanuel Pinteaux; Sheila Francis; Serena Sensi; Ádám Dénes; Andreas Goebel
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-10       Impact factor: 11.205

7.  Establishing the characteristics for patients with chronic Complex Regional Pain Syndrome: the value of the CRPS-UK Registry.

Authors:  Nicholas Shenker; Andreas Goebel; Mark Rockett; James Batchelor; Gareth T Jones; Richard Parker; Amanda C de C Williams; Candida McCabe
Journal:  Br J Pain       Date:  2015-05

8.  Complex regional pain syndrome patient immunoglobulin M has pronociceptive effects in the skin and spinal cord of tibia fracture mice.

Authors:  Tian-Zhi Guo; Tzuping Wei; Maral Tajerian; J David Clark; Frank Birklein; Andreas Goebel; Wen-Wu Li; Peyman Sahbaie; Fabiola L Escolano; Myriam Herrnberger; Heidrum H Kramer; Wade S Kingery
Journal:  Pain       Date:  2020-04       Impact factor: 7.926

Review 9.  Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II.

Authors:  Keith M Smart; Benedict M Wand; Neil E O'Connell
Journal:  Cochrane Database Syst Rev       Date:  2016-02-24

10.  Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study.

Authors:  Massimo Varenna; Vania Braga; Davide Gatti; Giovanni Iolascon; Bruno Frediani; Francesca Zucchi; Chiara Crotti; Fabrizio Nannipieri; Maurizio Rossini
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-11       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.